Inhibition of mitochondrial spare respiratory capacity by new securinine derivatives as a novel differentiation therapy for acute myeloid leukemia

被引：3
|
作者：
Karunanithi, Sheela [1 ]
Liu, Ruifu [1 ]
Roe, Anne [1 ]
Moreton, Stephen [1 ]
Hou, Yongchun [1 ]
Oldford, Natasha [1 ]
Goyco, Juan Valentin [1 ]
Wald, David [1 ]
机构：
[1] Case Western Reserve Univ, Wolstein Res Bldg, Cleveland, OH 44106 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-382
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
382
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia
    Schimmer, Aaron D.
    Skrtic, Marko
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (02) : 117 - 119
  • [22] A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy
    Luchen Sun
    Nanfei Yang
    Bing Chen
    Yuncheng Bei
    Zisheng Kang
    Can Zhang
    Nan Zhang
    Peipei Xu
    Wei Yang
    Jia Wei
    Jiangqiong Ke
    Weijian Sun
    Xiaokun Li
    Pingping Shen
    Acta Pharmaceutica Sinica B, 2023, (07) : 3027 - 3042
  • [23] A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy
    Sun, Luchen
    Yang, Nanfei
    Chen, Bing
    Bei, Yuncheng
    Kang, Zisheng
    Zhang, Can
    Zhang, Nan
    Xu, Peipei
    Yang, Wei
    Wei, Jia
    Ke, Jiangqiong
    Sun, Weijian
    Li, Xiaokun
    Shen, Pingping
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (07) : 3027 - 3042
  • [24] Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia
    Sykes, David B.
    Kfoury, Youmna S.
    Mercier, Francois E.
    Wawer, Mathias J.
    Law, Jason M.
    Haynes, Mark K.
    Lewis, Timothy A.
    Schajnovitz, Amir
    Jain, Esha
    Lee, Dongjun
    Meyer, Hanna
    Pierce, Kerry A.
    Tolliday, Nicola J.
    Waller, Anna
    Ferrara, Steven J.
    Eheim, Ashley L.
    Stoeckigt, Detlef
    Maxcy, Katrina L.
    Cobert, Julien M.
    Bachand, Jacqueline
    Szekely, Brian A.
    Mukherjee, Siddhartha
    Sklar, Larry A.
    Kotz, Joanne D.
    Clish, Clary B.
    Sadreyev, Ruslan I.
    Clemons, Paul A.
    Janzer, Andreas
    Schreiber, Stuart L.
    Scadden, David T.
    CELL, 2016, 167 (01) : 171 - +
  • [25] Inhibition Of Telomerase Is a Novel and Effective Therapy In MLL-Rearranged Acute Myeloid Leukemia (AML)
    Bruedigam, Claudia
    Bagger, Frederik Otzen
    Kuhn, Catherine Paine
    Therese Vu
    Austin, Rebecca
    Heidel, Florian H.
    Bullinger, Lars
    Hill, Geoff R.
    Armstrong, Scott A.
    Williams, David A.
    Lane, Steven W.
    BLOOD, 2013, 122 (21)
  • [26] Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia
    Jenkins, Christopher
    Hewamana, Saman
    Krige, David
    Pepper, Chris
    Burnett, Alan
    LEUKEMIA RESEARCH, 2011, 35 (05) : 677 - 681
  • [27] Mitochondrial metabolism: powering new directions in acute myeloid leukemia
    Stubbins, Ryan J.
    Maksakov, Irina A.
    Sanford, David S.
    Rouhi, Arefeh
    Kuchenbauer, Florian
    LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2331 - 2341
  • [28] Mitochondrial priming of new targeted agents in acute myeloid leukemia
    Ishizawa, Jo
    Kojima, Kensuke
    Duvvuri, Seshagiri R.
    McQueen, Teresa
    Ruvolo, Vivian R.
    Nogueras-Gonzalez, Graciela M.
    Huang, Xuelin
    Pierceall, William
    Cardone, Michael
    Lena, Ryan
    Doykan, Camille
    Shacham, Sharon
    Kauffman, Michael
    Konopleva, Marina
    Andreeff, Michael
    CANCER RESEARCH, 2014, 74 (19)
  • [29] DIFFERENTIATION OF MYELOID-LEUKEMIA CELLS - NEW POSSIBILITIES FOR THERAPY
    SACHS, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (04) : 509 - &
  • [30] The new perspectives of targeted therapy in acute myeloid leukemia
    Walasek, Angela
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (02): : 271 - 276
12345